Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Animal models of sepsis.

Zanotti-Cavazzoni SL, Goldfarb RD.

Crit Care Clin. 2009 Oct;25(4):703-19, vii-viii. doi: 10.1016/j.ccc.2009.08.005. Review.

PMID:
19892248
2.

The use of immunocompromised animals as models for human septic shock.

Opal SM, Cross AS.

Shock. 2005 Dec;24 Suppl 1:64-70.

PMID:
16374375
3.

Endotoxin as a drug target.

Opal SM, Glück T.

Crit Care Med. 2003 Jan;31(1 Suppl):S57-64. Review.

PMID:
12544978
4.

Mouse models of resuscitated shock.

Hollenberg SM.

Shock. 2005 Dec;24 Suppl 1:58-63. Review.

PMID:
16374374
5.

Animal models of sepsis: why does preclinical efficacy fail to translate to the clinical setting?

Dyson A, Singer M.

Crit Care Med. 2009 Jan;37(1 Suppl):S30-7. doi: 10.1097/CCM.0b013e3181922bd3. Review.

PMID:
19104223
6.

Experimental models of sepsis and their clinical relevance.

Poli-de-Figueiredo LF, Garrido AG, Nakagawa N, Sannomiya P.

Shock. 2008 Oct;30 Suppl 1:53-9. doi: 10.1097/SHK.0b013e318181a343. Review.

PMID:
18704008
7.

Introducing Critical Appraisal to studies of animal models investigating novel therapies in sepsis.

Piper RD, Cook DJ, Bone RC, Sibbald WJ.

Crit Care Med. 1996 Dec;24(12):2059-70. Review.

PMID:
8968277
8.

Possible therapies of septic shock: based on animal studies and clinical trials.

Wu CC.

Curr Pharm Des. 2006;12(27):3535-41. Review.

PMID:
17017946
9.

Hemodynamic, renal, and hormonal actions of aprotinin in an ovine model of septic shock.

Cumming AD, Nimmo GR.

Crit Care Med. 1992 Aug;20(8):1134-9.

PMID:
1379530
10.

Sophorolipids block lethal effects of septic shock in rats in a cecal ligation and puncture model of experimental sepsis.

Bluth MH, Kandil E, Mueller CM, Shah V, Lin YY, Zhang H, Dresner L, Lempert L, Nowakowski M, Gross R, Schulze R, Zenilman ME.

Crit Care Med. 2006 Jan;34(1):188-95.

PMID:
16374148
11.

Preclinical models of shock and sepsis: what can they tell us?

Marshall JC, Deitch E, Moldawer LL, Opal S, Redl H, van der Poll T.

Shock. 2005 Dec;24 Suppl 1:1-6. Review.

PMID:
16374365
12.

Sepsis and septic shock--a review of laboratory models and a proposal.

Wichterman KA, Baue AE, Chaudry IH.

J Surg Res. 1980 Aug;29(2):189-201. Review. No abstract available.

PMID:
6997619
13.

Rat intraperitoneal sepsis--a clinically relevant model.

Short BL, Gardiner WM, Walker RI, Fletcher JR, Rogers JE.

Circ Shock. 1983;10(4):351-9.

PMID:
6352075
14.

Corticosteroids for septic shock.

Annane D.

Crit Care Med. 2001 Jul;29(7 Suppl):S117-20. Review.

PMID:
11445745
15.

[Hemodynamics and aortic tension induced by two septic shock models in rats].

Xia ML, Wang M, Chai RK, Xu C, Wang HP, Xia Q.

Zhejiang Da Xue Xue Bao Yi Xue Ban. 2010 Nov;39(6):572-6. Chinese.

PMID:
21166049
16.

Nitric oxide synthase inhibition in septic shock--a question of the right time, the right drug, and the right model?

Bone HG.

Crit Care Med. 1998 Dec;26(12):1945-7. Review. No abstract available.

PMID:
9875895
17.

[Nitric oxide--an important mediator in sepsis?].

Kirkebøen KA, Strand OA.

Tidsskr Nor Laegeforen. 1999 Nov 10;119(27):4061-5. Review. Norwegian.

PMID:
10613098
18.

Use of nitric oxide synthase inhibitors to treat septic shock: the light has changed from yellow to red.

Cobb JP.

Crit Care Med. 1999 May;27(5):855-6. Review. No abstract available.

PMID:
10362394
19.

The rat in sepsis and endotoxic shock.

Wise WC, Cook JA, Tempel GE, Reines HD, Halushka PV.

Prog Clin Biol Res. 1989;299:243-52. Review.

PMID:
2657793
20.

Combination immunotherapy with soluble tumor necrosis factor receptors plus interleukin 1 receptor antagonist decreases sepsis mortality.

Remick DG, Call DR, Ebong SJ, Newcomb DE, Nybom P, Nemzek JA, Bolgos GE.

Crit Care Med. 2001 Mar;29(3):473-81.

PMID:
11373406

Supplemental Content

Support Center